Author: Leigh MacMillan
What protein is that?
Mar. 28, 2018—An improved technology enables high-throughput protein identification in imaging mass spectrometry, aiding proteomics research.
Voluntary exercise and energy balance
Mar. 23, 2018—Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.
Kidney disease imaging
Mar. 22, 2018—Making multiple measurements with MRI can provide comprehensive information about the molecular and cellular changes caused by kidney injury.
New imaging approach offers unprecedented views of staph infection
Mar. 15, 2018—A new integrated imaging approach makes it possible to probe the molecules involved in invasive infections and can be broadly applied to any health or disease state.
Botox for the shaky voice
Mar. 14, 2018—Vanderbilt investigators found that Botox injection into the vocal cords can lead to improved quality of life for patients with voice muscle problems.
Brain connections in schizophrenia
Mar. 9, 2018—Brain imaging studies have implicated the connection between two brain regions in the pathophysiology of schizophrenia.
Cancer immunotherapies expert Allison set for Discovery Lecture
Mar. 1, 2018—James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.
Structure of a stem cell niche
Feb. 28, 2018—Understanding the specialized environment where stem cells reside is important for developing stem-cell based regenerative therapies.
Cannabis compound reduces seizures
Feb. 26, 2018—Cannabidiol (CBD) oils reduced seizures in patients with difficult-to-treat epilepsy, Vanderbilt investigators have found.
Sepsis trial ranked No. 1 on critical care website
Feb. 15, 2018—A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.
A new target for neuroblastoma
Feb. 14, 2018—Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics.
Cognition in rare hormonal disorder
Feb. 13, 2018—Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder.